Kyle Garza, MBA, CPA, is a determined and collaborative financial and analytics leader in the pharmaceutical industry with experience in accounting, manufacturing, R&D, sales, and marketing. Currently, Kyle serves as the Analytics Senior Director at Eli Lilly, supporting the Mounjaro, Zepbound, and Jardiance brands in the Lilly Diabetes & Obesity organization. Previously, Kyle held various consulting and director roles within Eli Lilly, focusing on commercial analytics and financial consolidations. Kyle's educational background includes a Master of Business Administration from Indiana University - Kelley School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices